Merck
  • 主页
  • 查找结果
  • [The new possibility of therapy for medical personnel with metabolic syndrome].

[The new possibility of therapy for medical personnel with metabolic syndrome].

Meditsina truda i promyshlennaia ekologiia (2013-06-22)
P A Bakumov, E A Zerniukova, E R Grechkina
摘要

The possibility of magnesium deficiency correction was investigated in medical personnel with metabolic syndrome. It was shown that treatment with drugs containing magnesium leads to a decrease the cholesterol level.

材料
货号
品牌
产品描述

Sigma-Aldrich
胆固醇, Sigma Grade, ≥99%
Sigma-Aldrich
胆固醇, powder, BioReagent, suitable for cell culture, ≥99%
SAFC
胆固醇、植物的, SyntheChol®, NF, Ph. Eur., JP
Sigma-Aldrich
SyntheChol ® NS0 补充, 500 ×, synthetic cholesterol, animal component-free, sterile-filtered, aqueous solution, suitable for cell culture
Sigma-Aldrich
镁, turnings, reagent grade, 98%
Sigma-Aldrich
胆固醇, from sheep wool, ≥92.5% (GC), powder
Sigma-Aldrich
镁, purum, for Grignard reactions, ≥99.5%, turnings
Supelco
胆固醇 溶液, certified reference material, 10 mg/mL in chloroform
Sigma-Aldrich
镁, 20-230 mesh, reagent grade, 98%
Sigma-Aldrich
胆固醇, tested according to Ph. Eur.
Sigma-Aldrich
镁, grit, ≥99.0% (KT)
Sigma-Aldrich
镁, in a Sure/Seal bottle, turnings, 37.5 mmol
Sigma-Aldrich
镁, in a Sure/Seal bottle, turnings, anhydrous tetrahydrofuran 37.5 mmol